Comparative Efficacy of Silodosin vs Tamsulosin for Ureteric Calculus: A Single Centre Double Blind Randomised Controlled Trial

Journal Title: Journal of Medical Science And clinical Research - Year 2017, Vol 5, Issue 12

Abstract

Background: Ureteric calculus is now emerging as a major health concern irrespective of age of the patient due to the lifestyle changes. It can be managed both medically (MET) and surgically depending on various factors like it’s size number, site and comorbidities of patient. For Medical expulsion therapy we use α-blockers like tamsulosin, terazosin, doxazosin, silodosinetc but the effectiveness varies with each drug. So in this study we aim to compare the success rates of silodosin to tamsulosin for medical expulsive therapy of ureteral stones. Aim: As per many urological guidelines the patient can be started on MET unless there is absolute indication for intervention. Selective alfa 1 -adrenergic antagonists are now first-line drugs in MET. We conducted a prospective single-blind, parallel group, randomized, controlled trial to compare the effectiveness and safety of the alfa 1 –blocker silodosin versus tamsulosin in the treatment ureteric calculus. Materials and Methods: For this prospective single centre, double blind, randomised, placebo-controlled trial, our study group included adults aged 18-65 years undergoing expectant management for a single ureteric stone identified by CT. Participants were randomly assigned in a 1:1 ratio to tamsulosin 400 μg or silodosin 8 mg taken daily for up to 2 weeks. The primary outcome was the proportion of participants who did not need further intervention for stone clearance within 2 weeks. 173 patients were studied from October 2014 to July 2017 at VIMS, Ballari. This study was done after due clearance from ethical committee. Results: In our present study, the stone clearance rate was significantly higher in the silodosin group compared with the tamsulosin group, at 53% and 34%, respectively (P = 0.009). The status of stones was re assessed after 2 weeks using NCCT-KUB as the diagnostic modality. Those patients who could not expel stones after 2 weeks of MET were subjected to Ureteroscopic removal of stone. Conclusions: In conclusion, silodosin is more effective than tamsulosin as MET (Medical Expulsive Therapy) for ureteric calculus.

Authors and Affiliations

Dr Arun Antony

Keywords

Related Articles

Risk Factors and Angiographic Findings in Patients with LBBB Who Underwent Coronary Angiography in Duhok Heart Center

The objectives of this study were to determine presenting symptoms, risk factors, echocardiographic and angiographic findings in patients with Left bundle branch block (LBBB), who underwent coronary angiography in Duhok...

Role of Nifidipine in Preterm Labour - A Prospective Study

Background: Preterm labour and delivery remains a major cause of perinatal morbidity and mortality in the developing world. Numerous drugs and interventions have been used to prevent and inhibit the preterm labour but no...

Patterns of Distant Failure in Carcinoma Cervix- A Regional Cancer Centre Experience

Background: Cervical cancer is the most common malignancy among Indian females and is the leading cause of death. Patients with locally advanced cervical cancer after concurrent chemo radiation distant failure occur in m...

Diagnostic Accuracy of FNAC in Relation to Histopathology in Bone Tumors

Background: Bone tumors constitute approximately 1% of all tumors affecting the human body. The key to their accurate recognition is the utilization of an integrated approach that assesses and correlates the clinical, ra...

Rare Case of Pycnodysostosis: Case Report

It’s a rare disease of bone described under diastropic dwarfism. Inherited as autosomal recessive. Famous painter TOULOUSE LAUTREC had suffered from it. The term pycnodysastosis coined by Maroteaux and Lamy (1962)

Download PDF file
  • EP ID EP521164
  • DOI -
  • Views 86
  • Downloads 0

How To Cite

Dr Arun Antony (2017). Comparative Efficacy of Silodosin vs Tamsulosin for Ureteric Calculus: A Single Centre Double Blind Randomised Controlled Trial. Journal of Medical Science And clinical Research, 5(12), 31928-31932. https://europub.co.uk/articles/-A-521164